BioMAS Ltd Report issue

For profit Phase 2
Founded: Jerusalem Israel (2011)
Status: Defunct (2014)

Organization Overview

First Clinical Trial
2011
NCT00788424
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

as101 (1 trial)

as-101 (5 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Condylomata Acuminata (Phase 2)

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Leukemia (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Preleukemia (Phase 2)

Psoriasis (Phase 2)

Syndrome (Phase 2)

Thrombocytopenia (Phase 2)

Warts (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 2